Controlling environmental impact: an asset for drug production in France

The round table explores strategies for reducing the ecological footprint of pharmaceutical production. By meeting ecological and regulatory requirements, these approaches can boost competitiveness....

Charles FLAHAULT

Direction Générale des EntreprisesChargé de mission Décarbonation des Industries de Santé

Cécile KLINGUER

AP-HPDirectrice de la Transformation écologique et de la santé environnementale

Gildas BARREYRE

SEQENSSecrétaire général

Sébastien TAILLEMITE

ECOVAMEDPrésident

Ecovamed

Our Sessions

Controlling environmental impact: an asset for drug production in France

UGC

Personal data

Legal notices

Press